Saltar al contenido
Merck

25107

Sigma-Aldrich

Potassium citrate tribasic monohydrate

meets analytical specification of Ph. Eur., BP, FCC, E332, 99-100.5% (calc with ref. to anhyd. subst.)

Sinónimos:

Citric acid tripotassium salt, Tripotassium citrate

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
HOC(COOK)(CH2COOK)2 · H2O
Número de CAS:
Peso molecular:
324.41
Beilstein/REAXYS Number:
3924344
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.21

Quality Level

assay

99-100.5% (calc with ref. to anhyd. subst.)

form

powder or crystals

quality

meets analytical specification of Ph. Eur., BP, FCC, E332

impurities

≤0.0005% heavy metals (as Pb)
4-6% water (Karl Fischer)

loss

3-6 loss on drying, 180°C

pH

7-9 (20 °C, 5%)

mp

275 °C (dec.) (lit.)

solubility

glycerol: soluble 1 gm in 2.5 ml
water: soluble 1 gm in 0.65 ml
alcohol: insoluble

anion traces

chloride (Cl-): ≤30 mg/kg
oxalate (as oxalic acid): ≤100 mg/kg
sulfate (SO42-): ≤50 mg/kg

cation traces

As: ≤1 mg/kg
Cu: ≤10 mg/kg
Fe: ≤10 mg/kg
Hg: ≤1 mg/kg
Na: ≤3000 mg/kg
Pb: ≤1 mg/kg
Zn: ≤10 mg/kg

suitability

in accordance for appearance of solution
passes test for reaction against H2SO4

application(s)

pharmaceutical (small molecule)

SMILES string

O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3

InChI key

PJAHUDTUZRZBKM-UHFFFAOYSA-K

¿Está buscando productos similares? Visita Guía de comparación de productos

Application

Potassium citrate tribasic monohydrate has been used for preparing citrate-supplemented water for feeding the Car5A, Car5B, and DKO breeding pairs of mice. Citrate supplementation enhances the perinatal death in mice. It is a citrate-based salt used as a phase constituent for characterizing ionic-liquid-based aqueous biphasic systems (ABS) and as a buffering agent.

Biochem/physiol Actions

Potassium citrate tribasic monohydrate is the potassium salt of citric acid. It enhances the bone density hence used in the treatment of osteoporosis. Additionally, it neutralizes the protein-induced metabolic acidosis.

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 1

1 of 1

Good's buffers as a basis for developing self-buffering and biocompatible ionic liquids for biological research.
M. Taha, F. e Silva, M. V. Quental et al.
Green Chemistry (2014)
Antonia Fabris et al.
Clinical journal of the American Society of Nephrology : CJASN, 4(12), 1974-1979 (2009-10-08)
In medullary sponge kidney (MSK)-a common malformative renal condition in patients with calcium nephrolithiasis-hypercalciuria, incomplete distal renal tubular acidosis, and hypocitraturia are common. Clinical conditions with concomitant hypercalciuria and/or incomplete distal renal tubular acidosis are almost invariably associated with bone
Julie Mardon et al.
The Journal of nutrition, 138(4), 718-724 (2008-03-22)
High dietary protein intake generates endogenous acid production, which may adversely affect bone health. Alkaline potassium citrate (Kcit)(2) may contribute to the neutralization of the protein-induced metabolic acidosis. We investigated the impact of 2 levels of protein intake and Kcit
Characterization of aqueous biphasic systems composed of ionic liquids and a citrate-based biodegradable salt.
Helena Passos
Biochemical Engineering Journal, 67, 68- 76 (2012)
Clay Mechlin et al.
Journal of endourology, 25(9), 1541-1545 (2011-08-06)
Oral citrate supplements have been shown to decrease kidney stone recurrence rates in both laboratory and clinical studies. The taste of the citrate supplements, however, is poor, and long-term compliance is low. Our objective was to determine if Splenda(®) added

Contenido relacionado

Find solutions for bulk production, custom packaging, and personalized chemical services to meet your unique research, development, and manufacturing requirements in your industries, including pharmaceuticals, biotechnology, and research institutions.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico